Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Choosing to biopsy or refer suspicious melanocytic lesions in general practice

dc.contributor.authorRobison, Sean
dc.contributor.authorKljakovic, Marjan
dc.contributor.authorBarry, Peter
dc.date.accessioned2016-01-18T02:22:27Z
dc.date.available2016-01-18T02:22:27Z
dc.date.issued2012-08-08
dc.date.updated2016-02-24T08:55:33Z
dc.description.abstractBACKGROUND General practitioners (GPs) are involved in the management of most melanocytic skin lesions in Australia. A high quality biopsy technique is a crucial first step in management, as it is recognized that poor techniques can mislead, delay, or miss a diagnosis of melanoma. There has been little published on the biopsy decisions and techniques of GPs. This study aims to describe the current management choices made by GPs for suspicious melanocytic skin lesions and to compare their choices with the best practice guidelines. METHODS An anonymous survey of GPs presented with three clinical scenarios with increasing complexity of melanoma in which a referral or biopsy decision was specified. RESULTS 391 mailed surveys with a 76.3% response rate. Mean biopsy experience was 4.14 biopsies per GP per month. The rates of choosing to refer among the three scenarios were 31%, 52% and 81% respectively, with referral to surgery being the most common choice (81%). Most biopsy techniques (55%) were chosen according to best practice guidelines, although non-guideline biopsy techniques chosen included shave (n=10), punch biopsy (n=57), wide excisions (n=65), and flaps (n=10). The few GPs (n=5) who identified themselves as skin specialist GPs were no more likely to adhere to guidelines than their colleagues. CONCLUSION A majority of referrals and biopsies were chosen by GPs according to best practice guidelines, but concern remains for the high proportion of GPs making non-guideline based choices. How GPs choose to biopsy or refer needs further training, audit, and research if Australia is to improve the outcome of melanoma management in general practice.
dc.description.sponsorshipWe would like to thank the support of the staff at the Canberra Melanoma Unit and the Academic Unit of General Practice, Australian National University Medical School for their contribution to this study.en_AU
dc.identifier.issn1471-2296en_AU
dc.identifier.urihttp://hdl.handle.net/1885/95498
dc.publisherBioMed Central
dc.rights© Robison et al.; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.sourceBMC Family Practice
dc.subjectaustralia
dc.subjectbiopsy
dc.subjectdermoscopy
dc.subjectguideline adherence
dc.subjecthealth care surveys
dc.subjecthumans
dc.subjectmelanoma
dc.subjectphysician's practice patterns
dc.subjectpractice guidelines as topic
dc.subjectreferral and consultation
dc.subjectskin
dc.subjectskin neoplasms
dc.titleChoosing to biopsy or refer suspicious melanocytic lesions in general practice
dc.typeJournal article
local.bibliographicCitation.issue1en_AU
local.bibliographicCitation.lastpage6
local.bibliographicCitation.startpage78en_AU
local.contributor.affiliationRobison, Sean, College of Medicine, Biology and Environment, CMBE ANU Medical School, ANU Medical School, The Australian National Universityen_AU
local.contributor.affiliationKljakovic, Marjan, College of Medicine, Biology and Environment, CMBE ANU Medical School, ANU Medical School, The Australian National Universityen_AU
local.contributor.affiliationBarry, P, Canberra Melanoma Unit, Australiaen_AU
local.contributor.authoruidu4185854en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor111717en_AU
local.identifier.ariespublicationf5625xPUB2184en_AU
local.identifier.citationvolume13en_AU
local.identifier.doi10.1186/1471-2296-13-78en_AU
local.identifier.essn1471-2296en_AU
local.identifier.scopusID2-s2.0-84864532987
local.identifier.thomsonID000312413100004
local.publisher.urlhttp://www.biomedcentral.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Robison_Choosing_to_biopsy_or_refer_2012.pdf
Size:
171 KB
Format:
Adobe Portable Document Format
Description:
Published Version

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description: